Shopping Cart
- Remove All
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $196 | In Stock | |
5 mg | $493 | In Stock | |
10 mg | $830 | In Stock | |
25 mg | $1,480 | In Stock | |
50 mg | $1,960 | In Stock | |
100 mg | $2,690 | In Stock |
Description | Zidesamtinib (NVL-520) is an orally active, selective, potent, and blood-brain-barrier-crossing inhibitor of ROS1 fusion and resistance mutations, inhibits ROS1 and ROS1 G2032R, and can be used in the study of non-small-cell lung cancer and solid tumors. |
In vivo | Female athymic Nude-Foxn1nu mice were subcutaneously implanted with tumor fragments from the CTG-0848 model. Zidesamtinib (0.04, 0.2, 1, 5, 15 mg/kg; oral gavage twice daily for 21 days) inhibited tumor volumes[1]. |
Alias | NVL-520 |
Molecular Weight | 419.455 |
Formula | C22H22FN7O |
Cas No. | 2739829-00-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 30 mg/mL (71.52 mM), Sonification is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.